GlassScriptPhysician profile
Amy L Reano
NPI 1568054930
$4,800.49
in general payments reported to CMS, 2019-2025
31 companies · $1,303 in 2025
The $1,303 reported for 2025 was more than what 90% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $37.22 · 2022: $1,513 · 2023: $1,137 · 2024: $810 · 2025: $1,303.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,065 · Education: $186.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,064.80 |
| Education | $185.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $983.74 | 2022-2024 | Axonics |
| Medtronic, INC. | $912.23 | 2023-2025 | Interstim, Altaviva, Nuro |
| Janssen Biotech, INC. | $500.87 | 2022-2025 | Erleada, Akeega |
| Astellas Pharma US INC | $359.44 | 2022-2024 | Xtandi, Veozah, Myrbetriq |
| Myriad Genetic Laboratories, INC. | $276.65 | 2022-2024 | Myrisk, Prolaris |
| Abbvie INC. | $270.51 | 2022-2025 | |
| Olympus America INC. | $206.01 | 2025 | Itind System |
| Bayer Healthcare Pharmaceuticals INC. | $196.38 | 2023-2025 | |
| Tolmar, INC. | $181.86 | 2023-2025 | Eligard, Jatenzo |
| Pfizer INC. | $154.96 | 2023-2025 | |
| Accord Healthcare, INC. | $94.55 | 2023-2025 | |
| Urogen Pharma, INC. | $68.32 | 2023-2024 | Jelmyto |
| Boston Scientific Corporation | $58.86 | 2023-2025 | Spaceoar System, Ams 700 Cxr Rte Kit |
| 180 Medical, INC. | $49.00 | 2024-2025 | Gentlecath Glide |
| Endo Pharmaceuticals INC. | $45.70 | 2023 | Xiaflex, Aveed |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Blue Earth Diagnostics | $42.33 | 2022 | |
| Abc Home Medical Supply, INC. | $41.47 | 2022-2024 | |
| Urovant Sciences INC | $41.29 | 2022 | |
| Procept Biorobotics Corporation | $34.18 | 2024 | Aquabeam System |
| Sumitomo Pharma America, INC. | $33.21 | 2025 | Gemtesa |
| Baudax Bio INC. | $31.37 | 2022 | |
| Tolmar Pharmaceuticals, INC. | $30.57 | 2022 | |
| Caris Mpi, INC. | $29.59 | 2025 | Mi Cancer Seek |
| Convatec INC. | $29.28 | 2022-2023 | |
| Teleflex LLC | $25.87 | 2024 | Urolift |
| Coloplast Corp | $22.33 | 2025 | |
| Novartis Pharmaceuticals Corporation | $18.68 | 2021 | |
| Novo Nordisk INC | $18.54 | 2021 | |
| Endo USA, INC. | $15.18 | 2024 | Xiaflex |
| Merck Sharp & Dohme LLC | $13.97 | 2022 | |
| Angiodynamics, INC. | $13.55 | 2024 | Nanoknife |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Reano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.